The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The current study describes the impact of particle size and/or molecular targeting (epidermal growth factor, EGF) on the in vivo transport of block copolymer micelles (BCMs) in athymic mice bearing human breast cancer xenografts that express differential levels of EGF receptors (EGFR). BCMs with diameters of 25 nm (BCM-25) and 60 nm (BCM-60) were labeled with indium-111 ((111)In) or a fluorescent probe to provide a quantitative and qualitative means of evaluating their whole body, intratumoral, and subcellular distributions. BCM-25 was found to clear rapidly from the plasma compared to BCM-60, leading to an almost 2-fold decrease in their total tumor accumulation. However, the tumoral clearance of BCM-25 was delayed through EGF functionalization, enabling the targeted BCM-25 (T-BCM-25) to achieve a comparable level of total tumor deposition as the nontargeted BCM-60 (NT-BCM-60). Confocal fluorescence microscopy combined with MATLAB analyses revealed that NT-BCM-25 diffuses further away from the blood vessels (D(mean) = 42 +/- 9 microm) following extravasation, compared to NT-BCM-60 which mainly remains in the perivascular regions (D(mean) = 23 +/- 4 microm). The introduction of molecular targeting imposes the "binding site barrier" effect, which retards the tumor penetration of T-BCM-25 (D(mean) = 29 +/- 7 microm, p < 0.05). The intrinsic nuclear translocation property of EGF/EGFR leads to a significant increase in the nuclear uptake of T-BCM-25 in vitro and in vivo via active transport. Overall, these results highlight the need to consider multiple design parameters in the development of nanosystems for delivery of anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some previous studies, it was shown that sizes from 50 nm–100 nm are effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253, 254].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [254]
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Self-citationMicellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Research works printed but not linked: 6
- Yokota T., 1992, Cancer Res., 52, 3402
- Amiji, M. M.Nanotechnology for cancer therapy;CRC/Taylor & Francis:Boca Raton, 2007; p817,[8] of plates.
- Yuan F., 1995, Cancer Res., 55, 3752
- Juweid M., 1992, Cancer Res., 52, 5144
- Thurber G. M., 2008, Trends Pharmacol. Sci., 29, 57
- Costantini D. L., 2008, Cancer Biother. Radiopharm., 23, 3
Cited by
Items 101–200 of 348
Hirsjärvi, S., Dufort, S., Gravier, J., Texier, I., Yan, Q., Bibette, J., Sancey, L., Josserand, V., Passirani, C., Benoît, J., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.08.005 · Cited by 77
Cai, H., Liang, Z., Huang, W., Wen, L., & Chen, G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.084 · Cited by 78
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Yun, W. S., Kim, J., Lim, D.-K., Kim, D.-H., Jeon, S. I., & Kim, K. (2023) · Nanomaterials · doi:10.3390/nano13152225 · Cited by 76
Roy, A., Ernsting, M. J., Undzys, E., & Li, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.041 · Cited by 77
Deng, C., Zhang, Q., Fu, Y. S., Sun, X., Gong, T., & Zhang, Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13738 · Cited by 78
In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide
Simnick, A. J., Amiram, M., Liu, W., Hanna, G., Dewhirst, M. W., Kontos, C. D., & Chilkoti, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.044 · Cited by 83
Gill, M. R., Menon, J. U., Jarman, P. J., Owen, J., Skaripa-Koukelli, I., Able, S., Thomas, J. A., Carlisle, R. C., & Vallis, K. A. (2018) · Nanoscale · doi:10.1039/c7nr09606b · Cited by 83
Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for drug delivery applications
Verma, M. S., Liu, S., Chen, Y. Y., Meerasa, A., & Gu, F. X. (2012) · Nano Research · doi:10.1007/s12274-011-0184-z · Cited by 71
Pozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 79
Wang, Y., Ding, R., Zhang, Z., Zhong, C. F., Wang, J., & Wang, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120628 · Cited by 74
Polymeric Micelles for Neoadjuvant Cancer Therapy and Tumor-Primed Optical Imaging
Cho, H., & Kwon, G. S. (2011) · ACS Nano · doi:10.1021/nn202676u · Cited by 73
Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer
Xu, P., Meng, Q., Sun, H., Yin, Q., Yu, H., Zhang, Z., Cao, M., Zhang, Y., & Li, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.017 · Cited by 71
Limitations and niches of the active targeting approach for nanoparticle drug delivery
Chen, W. C., Zhang, A. X., & Li, S.-D. (2012) · ejnm · doi:10.1515/ejnm-2012-0010 · Cited by 66
Recent advances in gold and silver nanoparticle based therapies for lung and breast cancers
Malik, P., & Mukherjee, T. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.048 · Cited by 73
Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors
Naumenko, V. A., Vlasova, K. Y., Garanina, A. S., Melnikov, P. A., Potashnikova, D. M., Vishnevskiy, D. A., Vodopyanov, S. S., Chekhonin, V. P., Abakumov, M. A., & Majouga, A. G. (2019) · ACS Nano · doi:10.1021/acsnano.9b03848 · Cited by 66
Current understandings and clinical translation of nanomedicines for breast cancer therapy
Jiang, Y., Jiang, Z., Wang, M., & Ma, L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114034 · Cited by 72
Hoang, B., Reilly, R. M., & Allen, C. J. (2011) · Biomacromolecules · doi:10.1021/bm201479t · Cited by 71
Self-citationHirsjärvi, S., Sancey, L., Dufort, S., Daviaud, C., Vanpouille‐Box, C., Garcion, E., Coll, J., Hindré, F., & Benoît, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.057 · Cited by 63
Cancer Theranostics with Gold Nanoshells
Zhao, J., Wallace, M., & Melancon, M. P. (2014) · Nanomedicine · doi:10.2217/nnm.14.136 · Cited by 63
Ghorbani, M., Hamishehkar, H., Arsalani, N., & Entezami, A. A. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3097-z · Cited by 63
Wang, Z., & Tang, M. X. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4121 · Cited by 62
Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles
Lane, L. A. (2020) · Applied Physics Reviews · doi:10.1063/1.5052455 · Cited by 68
Song, W., Tang, Z., Zhang, D., Yu, H., & Chen, X. (2015) · Small · doi:10.1002/smll.201500324 · Cited by 61
Agarwal, R., & Roy, K. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.37 · Cited by 61
Guiding Principles in The Design of Ligand-Targeted Nanomedicines
Wang, X., Galliford, C. V., & Low, P. S. (2014) · Nanomedicine · doi:10.2217/nnm.13.175 · Cited by 66
Xu, P., Yu, H., Zhang, Z., Meng, Q., Sun, H., Chen, X., Yin, Q., & Li, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.030 · Cited by 61
Long Circulating liposomes: Challenges and Opportunities
Deodhar, S., & Dash, A. K. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0035 · Cited by 62
Microfluidic-assisted nanoprecipitation of antiviral-loaded polymeric nanoparticles
Bramosanti, M., Chronopoulou, L., Grillo, F., Valletta, A., & Palocci, C. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.04.062 · Cited by 63
Mikhail, A. S., Eetezadi, S., Ekdawi, S. N., Stewart, J., & Allen, C. J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.01.010 · Cited by 64
Self-citationBreaking biological barriers: Engineering polymeric nanoparticles for cancer therapy
Austria, E. S., Jr., Bilek, M., Varamini, P., & Akhavan, B. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102552 · Cited by 65
Nanomedicine: A New Frontier in Cancer Therapeutics
Lee, P. Y., & Wong, K. K. Y. (2011) · Current Drug Delivery · doi:10.2174/156720111795256110 · Cited by 62
Polymeric Nanoparticles for Cancer Photodynamic Therapy
Conte, C., Maiolino, S., Pellosi, D. S., Miro, A., Ungaro, F., & Quaglia, F. (2015) · Topics in current chemistry · doi:10.1007/978-3-319-22942-3_3 · Cited by 60
Lu, H. D., Yang, S. S., Wilson, B. K., McManus, S. A., Chen, C. V. H.-H., & Prud’homme, R. K. (2017) · Applied Nanoscience · doi:10.1007/s13204-017-0548-0 · Cited by 57
Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
Pant, K., Sedláček, O., Nadar, R. A., Hrubý, M., & Stephan, H. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601115 · Cited by 59
Ozcelikkale, A., Ghosh, S., & Han, B. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005947 · Cited by 55
Wang, L., Shi, C., Wright, F. A., Guo, D., Wang, X., Wang, D., Wojcikiewicz, R. J. H., & Luo, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3119 · Cited by 58
Jin, Y., Wu, Z., Wu, C., Zi, Y., Chu, X., Liu, J., & Zhang, W. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.040 · Cited by 53
Hauert, S., Berman, S., Nagpal, R., & Bhatia, S. N. (2013) · Nano Today · doi:10.1016/j.nantod.2013.11.001 · Cited by 53
Wang, R., Zhi, X., Yao, S., & Zhang, Y. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.05.030 · Cited by 52
Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors
Wang, Z., Wu, Z., Liu, J., & Zhang, W. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1420051 · Cited by 59
Νιώρα, Μ., Pedersbæk, D., Münter, R., Weywadt, M. F. D. V., Barooji, Y. F., Andresen, T. L., Simonsen, J. B., & Jauffred, L. (2020) · ACS Omega · doi:10.1021/acsomega.0c02879 · Cited by 56
Self‐Assembled Fluorescent Organic Nanomaterials for Biomedical Imaging
Zhang, K., Gao, Y., Yang, P., Qi, G., Zhang, J., Wang, L., & Wang, H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800344 · Cited by 51
Swetha, K. L., & Roy, A. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0578-5 · Cited by 60
Hoang, B., Ekdawi, S. N., Reilly, R. M., & Allen, C. J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400315p · Cited by 54
Self-citationVarache, M., Bezverkhyy, I., Saviot, L., Bouyer, F., Baras, F., & Bouyer, F. (2014) · Journal of Non-Crystalline Solids · doi:10.1016/j.jnoncrysol.2014.10.020 · Cited by 50
Wang, H., Fu, Z., Li, W., Li, Y., Zhao, L., Li, W., Zhang, J., & Wen, N. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s191069 · Cited by 51
Thomas, E., Menon, J. U., Owen, J., Skaripa-Koukelli, I., Wallington, S., Gray, M. D., Mannaris, C., Kersemans, V., Allen, P. D., Kinchesh, P., et al. (2019) · Theranostics · doi:10.7150/thno.34669 · Cited by 54
Extracellularly activatable nanocarriers for drug delivery to tumors
Abouelmagd, S. A., Hyun, H., & Yeo, Y. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.930434 · Cited by 59
Sunoqrot, S., Liu, Y., Kim, D., & Hong, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300560n · Cited by 48
Xu, H., Mao, K., Lu, C., Fan, Z.-L., Yang, J., Xu, J., Chen, P.-P., Zhuge, D., Shen, B., Jin, B., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.026 · Cited by 48
Li, H., Liu, J., Luo, Y., Chen, S.-B., Liu, R., Du, J., & Wang, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03913 · Cited by 47
Role of Endocytosis in Nanoparticle Penetration of 3D Pancreatic Cancer Spheroids
Durymanov, M. O., Kroll, C., Permyakova, A., & Reineke, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01078 · Cited by 45
Chen, T., Yan, P. F., Qiu, M., Yi, C., & Xu, Z. (2023) · Nanoscale · doi:10.1039/d3nr00280b · Cited by 50
Min, H. S., Kim, H. J., Ahn, J., Naito, M., Hayashi, K., Toh, K., Kim, B. S., Matsumura, Y., Kwon, I. C., Miyata, K., et al. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00507 · Cited by 45
Logie, J., Ganesh, A. N., Aman, A. M., Al‐awar, R., & Shoichet, M. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.026 · Cited by 46
Extra- and intra-cellular fate of nanocarriers under dynamic interactions with biology
Seo, S.-J., Chen, M., Wang, H., Kang, M. S., Leong, K. W., & Kim, H. (2017) · Nano Today · doi:10.1016/j.nantod.2017.04.011 · Cited by 52
Targeted delivery of nano-radiosensitizers for tumor radiotherapy
Shi, S., Zhong, H., Zhang, Y., & Mei, Q. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216101 · Cited by 45
Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin
Bandekar, A., Karve, S., Chang, M.-Y., Mu, Q., Rotolo, J. A., & Sofou, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.039 · Cited by 45
Bandekar, A., Zhu, C., Gomez, A., Menzenski, M. Z., Sempkowski, M., & Sofou, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002717 · Cited by 45
Roy, A., Zhao, Y., Yang, Y., Szeitz, A. J., Klassen, T., & Li, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.019 · Cited by 45
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Nichols, J. W., Sakurai, Y., Harashima, H., & Bae, Y. H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.003 · Cited by 44
Sims, L. B., Huss, M. K., Frieboes, H. B., & Steinbach-Rankins, J. M. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0298-x · Cited by 44
Wang, B., Zhai, Y., Shi, J., Zhuang, L., Liu, W., Zhang, H., Zhang, H., & Zhang, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.029 · Cited by 43
Viswanadh, M. K., Vikas, V., Jha, A., Adena, S. K. R., Mehata, A. K., Priya, V., Neogi, K., Poddar, S., Mahto, S. K., & Muthu, M. S. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0167 · Cited by 44
Recent advances of transformable nanoparticles for theranostics
Zhang, K., Yang, P., Zhang, J., Wang, L., & Wang, H. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.07.001 · Cited by 42
Gordon, M. R., Zhao, B., Anson, F., Fernandez, A. C., Singh, K., Homyak, C., Canakci, M., Vachet, R. W., & Thayumanavan, S. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.7b01659 · Cited by 46
Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems
Zhu, D., Long, Q., Xu, Y., & Xing, J. (2019) · Micromachines · doi:10.3390/mi10060414 · Cited by 43
Cong, Y., Ji, L., Gao, Y., Liu, F., Cheng, D., Hu, Z., Qiao, Z., & Wang, H. (2019) · Angewandte Chemie · doi:10.1002/ange.201900135 · Cited by 42
Applications of polymeric micelles with tumor targeted in chemotherapy
Ding, H., Wang, X., Zhang, S., & Liu, X. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-1254-1 · Cited by 41
Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields
Raoof, M., Cisneros, B. T., Guven, A., Phounsavath, S., Corr, S. J., Wilson, L. J., & Curley, S. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.033 · Cited by 39
Wang, J., Zhang, Y., Liu, L., Cui, Z., Liu, X., Wang, L., Li, Y., & Li, Q. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1629688 · Cited by 40
Cao, W., He, Y., Zhu, R., He, Y., Hao, Z., Zhao, Q., He, H., Wang, S., Li, C., & Gao, D. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122080 · Cited by 42
In situ construction of a self-assembled AIE probe for tumor hypoxia imaging
Xue, T., Shao, K., Xiang, J., Pan, X., Zhu, Z., & He, Y. (2020) · Nanoscale · doi:10.1039/d0nr00444h · Cited by 40
Tailoring Polymeric Micelles to Optimize Delivery to Solid Tumors
Li, W., Feng, S., & Guo, Y. (2012) · Nanomedicine · doi:10.2217/nnm.12.88 · Cited by 39
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 40
Octa-arginine boosts the penetration of elastin-like polypeptide nanoparticles in 3D cancer models
van Oppen, L. M. P. E., Pille, J., Stuut, C., van Stevendaal, M. H. M. E., van der Vorm, L. N., Smeitink, J. A. M., Koopman, W. J. H., Willems, P. H. G. M., van Hest, J. C. M., & Brock, R. E. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.02.010 · Cited by 37
d’Arcy, R., & Tirelli, N. (2014) · Polymers for Advanced Technologies · doi:10.1002/pat.3264 · Cited by 39
Wang, X., Shi, C., Zhang, L., Bodman, A., Guo, D., Wang, L., Hall, W. A., Wilkens, S., & Luo, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.006 · Cited by 36
Kesharwani, P., Chandra, J., Karim, S., Gupta, G., Karwasra, R., & Sharma, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105663 · Cited by 53
Xu, J., Lee, S. S., Seo, H., Pang, L., Jun, Y., Zhang, R., Zhang, Z., Kim, P., Lee, W., Kron, S. J., et al. (2018) · Small · doi:10.1002/smll.201803601 · Cited by 39
He, T., Wang, H., Wang, T., Pang, G., Zhang, Y., Zhang, C., Yu, P., & Chang, J. K. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127173 · Cited by 36
Design of disintegrable nanoassemblies to release multiple small-sized nanoparticles
Zhu, D., Yan, H., Zhou, Y., Nack, L., Liu, J., & Parak, W. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114854 · Cited by 38
Core–shell nanoparticles as a drug delivery platform for tumor targeting
Dhas, N. L., Raval, N. J., Kudarha, R. R., Acharya, N. S., & Acharya, S. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00009-2 · Cited by 35
Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting
Kim, H. J., Yi, Y., Kim, A., & Miyata, K. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00546 · Cited by 35
Goas, M. L., Testard, F., Taché, O., Debou, N., Cambien, B., Carrot, G., & Renault, J. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c01624 · Cited by 37
Wang, X., & Zhou, H. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.008 · Cited by 34
Li, X., Zhong, H., Zheng, S., Mu, J., Yu, N., & Guo, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.004 · Cited by 32
Patel, T., Kevadiya, B. D., Bajwa, N., Singh, P. A., Zheng, H., Kirabo, A., Li, Y., & Patel, K. P. (2023) · Antioxidants · doi:10.3390/antiox12101877 · Cited by 38
Quantifying the Plasmonic Nanoparticle Size Effect on Photoacoustic Conversion Efficiency
Shi, Y., Yang, S., & Xing, D. (2017) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.6b12498 · Cited by 30
A universal discoidal nanoplatform for the intracellular delivery of PNAs
Rad, A. T., Malik, S., Yang, L., Oberoi‐Khanuja, T. K., Nieh, M., & Bahal, R. (2019) · Nanoscale · doi:10.1039/c9nr03667a · Cited by 30
Wáng, Y. X. J., Idée, J., & Corot, C. (2015) · Nanoscale · doi:10.1039/c5nr03887a · Cited by 28
Radioactive Nanoparticles and their Main Applications: Recent Advances
Kharisov, B. I., Kharissova, O. V., & Бердоносов, С. С. (2014) · Recent Patents on Nanotechnology · doi:10.2174/187221050802140618143846 · Cited by 29
Shen, J., Shao, K., Zhang, W., & He, Y. (2021) · ACS Macro Letters · doi:10.1021/acsmacrolett.1c00183 · Cited by 29
The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies
Singh, V. K., Saini, A., & Chandra, R. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00052 · Cited by 31
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Qin, M., Xia, H., Xu, W., Chen, B., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115137 · Cited by 33
Pang, Z., Wu, J., Zhao, J., Zhang, B., Qian, Y. J., Gao, H., Yan, W., Yang, Z. H., Jiang, X., & Yu, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72649 · Cited by 28
Barkey, N. M., Preihs, C., Cornnell, H. H., Martinez, G. V., Carie, A., Vágner, J., Xu, L., Lloyd, M. C., Lynch, V. M., Hruby, V. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005576 · Cited by 33
Precisely Tunable Engineering of Sub-30 nm Monodisperse Oligonucleotide Nanoparticles
Sizovs, A., Song, X., Waxham, M. N., Jia, Y., Feng, F., Chen, J., Wicker, A. C., Xu, J., Yu, Y., & Wang, J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408879b · Cited by 27
Соколова, Е. А., Kutova, O. M., Grishina, A., Pospelov, A. D., Guryev, E. L., Schulga, A. A., Deyev, S. M., & Balalaeva, I. V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050219 · Cited by 28
Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy
Song, W., Tang, Z., Zhang, D., Wen, X., Lv, S., Liu, Z., Deng, M., & Chen, X. (2016) · Theranostics · doi:10.7150/thno.14741 · Cited by 27
Metadata
- Authors
- Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Allen, Christine
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-26
- Volume
- 7
- Issue
- 4
- Pages
- 1195-1208
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1985006200
- Cited by
- 349
- References
- 46
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 18 · 2023: 15 · 2022: 10 · 2021: 24 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 35 · 2016: 26 · 2015: 24 · 2014: 28 · 2013: 26 · 2012: 24
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymeric nanoparticles, block copolymer micelles, particle size, molecular targeting, epidermal growth factor, EGFR, intratumoral distribution, subcellular localization, tumor penetration, nuclear translocation, tumor xenografts, breast cancer, indium-111 labeling, nanoparticle clearance
- MeSH terms
- Animals, Breast Neoplasms, Drug Carriers, Epidermal Growth Factor, Female, Humans, Mice, Nude, Particle Size, Polymers, Microscopy, Confocal, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.